Tuesday | Wednesday | Thursday | Friday | Saturday
TUESDAY, DECEMBER 5, 2017
8:00 am - 7:00 pm REGISTRATION - Main Lobby  
 

Pre-registered attendees can obtain materials. Those who have not yet registered may do so.

 

11:00 am - 12:45 pm

INTERNATIONAL SESSION - Global View of Value Based Medicine – Hemisfair Ballroom 2&3 - 3rd Level
Moderator: Peggy Porter, MD
Fred Hutchinson Cancer Research Center
Seattle, WA

Health system responses to women's cancers in the Americas: Closing divides to achieve universal health coverage
Felicia M. Knaul, PhD
University of Miami
Miami, FL

The challenge of definition and adoption; perspective from the Middle East
Sana Al Sukhun, MD, MSc
Jordanian Oncology Society
Amman, JORDAN

Breast imaging in resource constrained regions: Lessons from Uganda
Constance D. Lehman, MD, PhD
Massachusetts General Hospital
Boston, MA

 
     
 11:00 am - 12:45 pm WORKSHOPS  
  Molecular Biology in Breast Oncology - Stars at Night Ballroom 1&2 - 3rd Level
Moderator: Carlos L. Arteaga, MD
Vanderbilt University Medical Center
Vanderbilt-Ingram Cancer Center
Nashville, TN

Drug target discovery: how to go about it?
Markus Warmuth, MD
H3 Biomedicine
Cambridge, MA

Bench-based approaches to discover mechanisms of drug resistance (i.e. CRISPR, genome library screens, etc.)
Nikhil Wagle, MD
Dana-Farber Cancer Institute
Boston, MA

Genomics & bioinformatics (big data) in breast cancer research
Mia Levy, MD, PhD
Vanderbilt University Medical Center
Nashville, TN

Single cell genomics and tumor heterogeneity
Jorge S. Reis-Filho, MD, PhD
Memorial Sloan Kettering Cancer Center
New York, NY

 
     
  Methods in Breast Cancer Clinical Research - Stars at Night Ballroom 3&4 - 3rd Level
Moderator: Virginia G. Kaklamani, MD
UT Health San Antonio
San Antonio, TX

Novel statistical clinical trial designs
Yu Shyr, PhD
Vanderbilt Ingram Cancer Center
Nashville, TN

Incorporating biomarkers in clinical trials
Edith Perez, MD
Genentech
South San Francisco, CA

What about neoadjuvant trials and path CR
Hope Rugo, MD
University of California
San Francisco, CA

Regulatory issues
Tatiana M. Prowell, MD
FDA/Johns Hopkins
Silver Springs, MD

 
     
1:00 pm - 6:00 pm

EDUCATIONAL SESSIONS - Stars at Night Ballrooms 1&2, 3&4 and Hemisfair Ballroom 2&3 - 3rd Level

Updates on advances in key areas and in technologies available for translational research. Many of these sessions will provide attendees with a better understanding of the background leading up to talks they will hear in the succeeding days, and some of the techniques that will be used. These presentations should also provide researchers with ideas and techniques to be considered for their own studies.

 
     
1:00 pm - 2:30 pm

Shifting Paradigms in Radiation Oncology – Hemisfair Ballroom 2&3 - 3rd Level
Moderator: Richard L. Crownover, MD, PhD
UT Health San Antonio
San Antonio, TX

Accelerated partial breast irradiation: Update of an ASTRO consensus guideline
Candace R. Correa, MD
Community Cancer Center
Normal, IL

Guidelines for postmastectomy radiotherapy
Abram Recht, MD, FASTRO, FASCO
Beth Israel Deaconess Medical Center
Boston, MA

Advanced technologies to optimize outcomes and minimize toxicities
Reshma Jagsi, MD, DPhil
University of Michigan
Ann Arbor, MI

Changing Recommendations for Intermediate Risk Lesions - Stars at Night Ballroom 1&2 - 3rd Level
Moderator: Virginia G. Kaklamani, MD
UT Health San Antonio
San Antonio, TX

The pathology of high risk proliferative lesions of the breast
Kalliopi P. Siziopikou, MD, PhD
Northwestern University
Chicago, IL

Clinical management of women with increased breast cancer risk based on histologic lesions
Amy C. Degnim, MD
Mayo Clinic
Rochester, MN

Managing increased breast cancer risk based on high and moderate penetrance gene mutations
Judy E. Garber, MD, MPH
Dana-Farber Cancer Institute
Boston, MA

Beyond Expression Profiling: RNA Epigenetics  Stars at Night Ballroom 3&4 - 3rd Level
Moderator:  Douglas Yee, MD
University of Minnesota
Minneapolis, MN

Drugging protein synthesis in cancer therapy
Robert J. Schneider, PhD
New York University
New York, NY

Targeting RNA splicing in cancer therapy
Stephan Vagner, PhD
Institut Curie-Centre de Recherche
Orsay, FRANCE

Progress, paradigms, and pathways of long non-coding RNAs in cancer
Liuqing Yang, PhD
UT MD Anderson Cancer Center
Houston, TX

 
     
2:45 pm - 4:15 pm

Medical Treatment of HER2+++ Breast Cancer – Hemisfair Ballroom 2&3 - 3rd Level
Moderator:  Angelo Di Leo, MD, PhD
Hospital of Prato
Prato, ITALY

HER2 testing - 2017 guidelines for HER2 testing
Robert B. Jenkins, MD, PhD
Mayo Clinic
Rochester, MN

Adjuvant therapy for HER2-positive breast cancers: Is less more?
Ruth M. O'Regan, MD
University of Wisconsin
Madison, WI

Can we improve treatment tailoring in advanced HER2+ breast cancer?
Martine J. Piccart, MD, PhD
Institut Jules Bordet
Brussels, BELGIUM

Multi-Level Influences on Breast Cancer Disparities – Stars at Night Ballroom 1&2 - 3rd Level
Moderator: Melissa L. Bondy, PhD
Baylor College of Medicine
Houston, TX

Place as a cause of breast cancer disparities in Appalachia
Electra D. Paskett, BS, MSPH, PhD
Ohio State University
Columbus, OH

Biologic, cultural and health systems influences on breast cancer disparities in Latinas 
Amelie G. Ramirez, DrPH
UT Health San Antonio
San Antonio, TX

Biologic and health system determinants of breast cancer disparities in African Americans
Katherine E. Reeder-Hayes, MD
University of North Carolina
Chapel Hill, NC

Panel Discussion

The Breast Tumor Microenvironment: A Target for Therapy  Stars at Night Ballroom 3&4 - 3rd Level
Moderator:  Leisha A. Emens, MD, PhD
Johns Hopkins University
Baltimore, MD

How tumor metabolism contributes to the immunosuppressive microenvironment
Jeffrey C. Rathmell, PhD
Vanderbilt University
Nashville, TN

Do tumors overcome immune surveillance by blocking dendritic cell development
David G. DeNardo, PhD
Washington University School of Medicine
St. Louis, MO

Opportunities for immune therapy and prevention
Robert H. Vonderheide, MD, DPhil
University of Pennsylvania
Philadelphia, PA

 
     
4:30 pm - 6:00 pm

Management Controversies in Locoregional Recurrence - Hemisfair Ballroom 2&3 - 3rd Level
Moderator:  Irene Wapnir, MD
Stanford Women's Cancer Center
Stanford, CA

Challenges in the management of locoregional recurrence
Monica Morrow, MD
Memorial Sloan Kettering Cancer Center
New York, NY

Local regional recurrence
Richard C. Zellars, MD
Indiana University
Indianapolis, IN

Should all patients with locoregional recurrence receive systemic therapy?
William J. Gradishar, MD
Northwestern University
Chicago, IL


Circulating Tumor Cells and Liquid Biopsies, Translation to Clinical Practice – Stars at Night Ballroom 1&2 - 3rd Level
Moderator:  Matthew J. Ellis, MD, PhD
Baylor College of Medicine
Houston, TX

Liquid biopsies in breast cancer - challenges and opportunities
Sarah-Jane Dawson, MBBS (Hons), FRACP, PhD (Cantab)
Peter MacCallum Cancer Centre
Melbourne, AUSTRALIA

Exosome analysis in breast cancer: Clinical translation
Jacqueline F. Bromberg, MD, PhD
Memorial Sloan Kettering Cancer Center
New York, NY

Circulating complexes of stromal and tumor cells in breast cancer metastasis
Dorraya El-Ashry, PhD
University of Minnesota
Minneapolis, MN

Androgen, Progesterone and Glucocorticoid Receptors: Drivers of Breast Tumor Progression or Reprogramming of Steroid Receptors During Breast Tumor Progression - Stars at Night Ballroom 3&4 - 3rd Level
Moderator:  Suzanne A.W. Fuqua, PhD
Baylor College of Medicine
Houston, TX

Androgen receptor in breast cancer.  When might it serve as a suitable target?
Jennifer K. Richer, PhD
University of Colorado
Aurora, CO

Tracking progesterone receptor actions in breast cancer progression: Jekyll and Hyde
Carol A. Lange, PhD
University of Minnesota
Minneapolis, MN

Androgen, Progesterone and Glucocorticoid Receptors: Drivers of breast tumor progression or reprogramming of steroid receptors during breast tumor progression
Suzanne D. Conzen, MD
University of Chicago
Chicago, IL

 
     
 6:00 pm - 8:00 pm RECEPTION  
     
 8:00 pm - 10:00 pm OPEN SATELLITE EVENT hosted by Dr. Neil Love and Research to Practice - Marriott Rivercenter

DATA + PERSPECTIVES: Clinical Investigators Explore the Emerging Role of PARP Inhibition in the Management of Breast Cancer

For more information and to register for this event, please click on the link below:
http://www.researchtopractice.com/Meetings/PARP2017

 

 
Tuesday | Wednesday | Thursday | Friday | Saturday